Clinical Trials Sponsored by Anthony Sung, MD

Total 57 results

Anthony Sung, MD
Massachusetts General Hospital

Completed

Pasireotide in Prevention of GI Toxicity

Hematological Malignancies

United States
Lowell Anthony, MD

Terminated

Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression

Neuroendocrine Tumors | Everolimus

United States
Lowell Anthony, MD
TerSera Therapeutics LLC

Terminated

Telotristat With Lutathera in Neuroendocrine Tumors

Neuroendocrine Tumors

United States
Lowell Anthony, MD
Entrinsic Bioscience Inc.

Completed

Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs

Diarrhea | Neuroendocrine Tumors | Carcinoid Syndrome | Carcinoid Tumor of GI System

United States
Anthony Costales, MD
The Cleveland Clinic

Recruiting

Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer (MAN-U)

ENDOMETRIAL CANCER

United States
Anthony J Viera, MD, MPH
North Carolina Translational and Clinical Sciences Institute

Completed

Ambulatory vs Office BP Management Usual Care for Diagnosing and Managing Hypertension: A Pilot Study

Hypertension

United States
Chunyan Sun, MD

Recruiting

ATG-010(Selinexor) in Combination With Chemotherapy in RRMM

Multiple Myeloma

China
Li Zhang, MD

Not yet recruiting

Phase III Study Comparing Osimertinib Monotherapy to Combination Therapy With Osimertinib,Carboplatin and Pemetrexed for Untreated Patients With Advanced Non-squamous Non-Small Cell Lung Cancer With Concurrent EGFR and TP53 Mutations (TOP)

Non-small Cell Carcinoma | EGFR Gene Mutation

China
Li Zhang, MD

Recruiting

An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese

Small Cell Lung Cancer | Lung Cancer | Durvalumab

China
Li Zhang, MD

Recruiting

Ensatinib Treat Second-generation ALK-TKI Resistance After Second-generation ALK-TKI Resistance (ERSGATR)

The Diagnosis Was ALK Positive NSCLC | Second Generation ALK-TKI is Resistant | Efficacy of Ensatinib in This Subset of Patients

China
Li Zhang, MD

Recruiting

Surufatinib Combined With Toripalimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

China
Li Zhang, MD

Not yet recruiting

JS001 Combination Therapy in NSCLC Negative Driving Gene After First-line Chemotherapy.

Non-small Cell Lung Cancer

China
Weijing Sun, MD, FACP

Withdrawn

A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach

Adenocarcinoma | Stomach Cancer

United States
Chun-Hua Wang, MD

Unknown

Role of NLRP3 Inflammasone and Hypoxia in the Severity of Osteoporosis in Patients With Bronchiectasis

Bronchiectasis Adult | Osteoporosis, Osteopenia

Taiwan
Phillip Song, MD

Withdrawn

Efficacy Study of Botulinum Toxin (BOTOX) Injections to Treat Vocal Fold Granulomas

Granuloma | Contact Ulcer of Vocal Folds | Granuloma of Vocal Cords | Granuloma, Laryngeal

United States
Anne Fung MD
Genentech, Inc.

Terminated

HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration (HiPED)

Macular Degeneration | Wet Macular Degeneration | Retinal Pigment Epithelial Detachment

United States
Weijing Sun, MD, FACP
Amgen

Completed

Phase II Study of Irinotecan and Panitumumab

Esophageal Cancer

United States
Rui-hua Xu, MD, PhD

Not yet recruiting

A Phase II Study of Surufatinib Combined With PD-L1 and mFOLFOX6 as Second-line Treatment for Advanced PRAD

Advanced Pancreatic Cancer

China
Kawut, Steven, MD
National Heart, Lung, and Blood Institute (NHLBI); Columbia University

Completed

A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial Hypertension

Hypertension, Pulmonary

United States
Xianmin Song, MD

Recruiting

Next Generation Sequencing（NGS）Monitors Minimal Residual Disease（MRD）in Allo-PBSCT Patients

NGS Monitor MRD

China
Po-Lin Chen, MD
Grape King Bio Ltd.

Completed

Probiotics for Liver Cirrhosis With Portal Hypertension

Liver Cirrhosis | Portal Hypertension

Taiwan
Xianmin Song, MD

Recruiting

Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies

Leukemia, Myeloid, Acute | Myeloid Malignancy | MDS | Hematopoietic Stem Cell Transplantation

China
Gladwin, Mark, MD
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE) (SCD-CARRE)

Sickle Cell Disease

United States, France, Brazil
Matthew Neal MD
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE (ACTIV-4A)

Covid19

United States, Spain, Brazil, Italy
Gladwin, Mark, MD
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (PH-HFpEF)

Heart Failure | Pulmonary Hypertension Secondary

United States
Gladwin, Mark, MD
National Heart, Lung, and Blood Institute (NHLBI)

Completed

A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction (PMED)

Heart Failure | Preserved Ejection Fraction | Pulmonary; Hypertension

United States
Christine Lau, MD
National Heart, Lung, and Blood Institute (NHLBI)

Unknown

Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation

Lung Transplant

United States
Gladwin, Mark, MD
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Transfusion of Biotin-Labeled Red Blood Cells

Healthy Volunteers

United States
Joselyn Cerezo, MD
National Heart, Lung, and Blood Institute (NHLBI)

Unknown

Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) (CLEVER)

Cardiovascular Diseases | Peripheral Vascular Diseases | Atherosclerosis

United States, Canada
Karolinska Institutet
Karolinska University Hospital; The Swedish Research Council; Swedish Heart Lung... and other collaborators

Recruiting

Home Monitoring and Molecular Phenotyping of Patients With Post-COVID With Focus on Lung Involvement (HemCOV)

Long COVID

Sweden
Elliot Israel, MD
National Heart, Lung, and Blood Institute (NHLBI)

Completed

The Severe Asthma Research Program III-Boston Clinical Site (SARPIII-AMSA)

Asthma

United States
Laura M. De Castro, MD
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Study of Propranolol as Anti-Adhesive Therapy in Sickle Cell Disease (SCD)

Sickle Cell Disease

United States
Ivan FN Hung MD
Pamela Youde Nethersole Eastern Hospital

Recruiting

Olfactory and Neurosensory Rehabilitation in COVID-19-related Olfactory Dysfunction

Coronavirus Disease 2019

Hong Kong
Dennis M. McNamara, MD, MS
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy (REBIRTH)

Peripartum Cardiomyopathy, Postpartum

United States
Gladwin, Mark, MD
National Heart, Lung, and Blood Institute (NHLBI); Complexa, Inc.

Terminated

Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

United States
Juan Celedon, MD
National Heart, Lung, and Blood Institute (NHLBI); Pharmavite LLC

Terminated

Vitamin D to Prevent Severe Asthma Exacerbations (Vit-D-Kids Asthma)

Asthma

United States
University of Michigan
National Heart, Lung, and Blood Institute (NHLBI); Kennedy Krieger Institute...

Recruiting

Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)

Hypoxia-Ischemia, Brain | Cardiac Arrest, Out-Of-Hospital | Hypothermia, Induced

United States, Canada, United Kingdom
Tracie Collins, MD, MPH
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Motivational Interviewing (MI) for African Americans With Peripheral Arterial Disease (PAD) Pilot

Peripheral Arterial Disease

United States
Jeffrey Zwicker, MD
National Heart, Lung, and Blood Institute (NHLBI); Quercegen Pharmaceuticals

Completed

Cancer Associated Thrombosis and Isoquercetin (CATIQ) (CATIQ)

Thromboembolism of Vein VTE in Colorectal Cancer | Thromboembolism of Vein in Pancreatic Cancer | Thromboembolism of Vein in Non-small Cell Lung Cancer

United States
Mazonson & Santas Inc.
University of California, San Diego; University of Wisconsin, Madison; Stanford... and other collaborators

Unknown

Aging With Dignity, Health, Optimism and Community (ADHOC)

HIV

United States
Richard E. Ostlund Jr., MD
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Physiological Study of Human Cholesterol Metabolism and Excretion

Cardiovascular Disease | Dyslipidemia | Coronary Heart Disease | Disorder of Cholesterol Metabolism

United States
Gladwin, Mark, MD
National Heart, Lung, and Blood Institute (NHLBI); University of Pittsburgh; National...

Withdrawn

Chlorhexidine Mouthwash and Oral Nitrate in Adults With Pulmonary Hypertension

Pulmonary Hypertension | Heart Failure With Normal Ejection Fraction | Pulmonary Heart Disease and Diseases of Pulmonary Circulation

United States
Ole Frobert, MD, PhD
Uppsala University; Sanofi Pasteur, a Sanofi Company; Swedish Heart Lung Foundation and other collaborators

Completed

Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis (IAMI)

Myocardial Infarction | Heart Failure | Stroke | Influenza, Human | Influenza Vaccines

Denmark, United Kingdom, Sweden, Australia, Bangladesh, Czechia, Latvia, Norway
Sang Hyun Ihm, MD PhD
Daiichi Sankyo Korea Co., Ltd.; Daewoong Pharmaceutical Co. LTD.

Completed

Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM (EARTH)

Hypertension

Korea, Republic of
Fred Wamboldt, MD
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaborators

Completed

Heart Rate Variability Biofeedback: It's Role in Asthma Therapeutics (BioAce)

Asthma

United States
Miguel X. Valderrabano, MD
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaborators

Completed

Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation (VOM-R01)

Atrial Fibrillation | Ventricular Tachycardia

United States
Denice Hodgson-Zingman, MD
National Heart, Lung, and Blood Institute (NHLBI); The Cleveland Clinic; National...

Not yet recruiting

Paced Heart Rate Acceleration for Cardiac Conditioning (HeartExcel)

Heart Failure, Systolic
Francesca Facco, MD
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Sleep Disordered Breathing, Obesity and Pregnancy Study (SOAP) (SOAP)

Pregnancy | Sleep Disordered Breathing | Obese

United States
Marcelo Pasquini, MD
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Active, not recruiting

MM CAR-T to Upgrade Response BMTCTN1902

Multiple Myeloma

United States
Hongqi Zhang, MD
General Hospital of Chinese Armed Police Forces; Beijing Tiantan Hospital; Chinese... and other collaborators

Unknown

Surgical Intervention of Spinal Arteriovenous Malformations and Fistulas (SUIT-SAVM)

Spinal Cord Vascular Diseases

China

Clinical Trials Sponsored by Anthony Sung, MD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations